Effect of galantamine hydrobromide in chronic fatigue syndrome: a randomized controlled trial.

Context: There is no established pharmacological treatment for the core symptoms of chronic fatigue syndrome (CFS). Galantamine hydrobromide, an acetyl cholesterone inhibitor, has pharmacological properties that might benefit patients with CFS.

Objective: To compare the efficacy and tolerability of galantamine hydrobromide in patients with CFS.